Xeloda 500 (Capecitabine Tablet) 500mg

Xeloda 500 (Capecitabine 500mg) is an oral chemotherapy tablet used for cancer treatment. It belongs to the fluoropyrimidine class and is prescribed for various solid tumors. Store at room temperature in a dry place. Always follow healthcare provider instructions.

Strength

500mg

Pack Size

120s

Storage

Ambient

Manufacturer / TM Owner

Cheplapharm

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Capecitabine 500mg tablets are prescribed to treat certain types of cancer, including colorectal and breast cancers. It may also be used for gastric cancer in combination with other medications. This chemotherapy works by interfering with cancer cell growth. Patients often ask, 'what is Xeloda 500 used for' when discussing treatment options with their doctor.

Side Effects

Xeloda 500 may cause mild to moderate side effects such as nausea, fatigue, or hand-foot syndrome. Some users report changes in appetite or mild stomach discomfort. These effects vary by individual and are typically temporary. Always report persistent symptoms to a healthcare professional.

Precautions & Warnings

Keep Xeloda 500 tablets in their original packaging away from moisture and direct sunlight. Store at room temperature and avoid crushing or splitting tablets unless directed. Wash hands thoroughly after handling. Do not share this medication with others, even if they have similar symptoms.

Avoid Interactions

Capecitabine may interact with blood thinners, certain antacids, or other chemotherapy drugs. Alcohol and grapefruit products can also affect how this medication works. Always inform your doctor about all medications and supplements you are taking. Some interactions may require dose adjustments.

Frequently Asked Questions

Take Xeloda 500 exactly as prescribed by your doctor, usually with water within 30 minutes after a meal.

Common side effects include nausea, diarrhea, fatigue, and hand-foot syndrome. Report severe symptoms to your healthcare provider.

Do not split or crush Xeloca 500 tablets unless instructed by your doctor. Handle with care to avoid exposure.

Xeloda 500 may harm an unborn baby. Avoid use during pregnancy and discuss contraception with your doctor.

Store Xeloca 500 at room temperature in a dry place, away from children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.